Historical record - last NADAC publication: 2/17/2021

Product Information

NAPROXEN 375 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0736 per EA under NDC 69097085407. Its NADAC has been published 229 times since Oct 12, 2016.

The High Outlier badge above means this manufacturer's average price in the naproxen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

NAPROXEN 375 MG TABLET

naproxen
$0.0736per EA
High Outlier

Strength

375 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097085407

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

2/17/2021

Active Ingredients

NAPROXEN

Approval Type

Generic (ANDA)

FDA Application

ANDA091305

On Market Since

7/5/2016

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for NAPROXEN 375 MG TABLET has been published 229 times since Oct 12, 2016, and over the history we have for it it has risen 29.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0736 per EA
All-time high$0.0801 (Nov 13, 2019)
All-time low$0.0548 (Jul 19, 2017)
Median price$0.0653
Average price$0.0666
Largest weekly change+14.4% (Apr 17, 2019)
Weeks tracked229
Tracking sinceOct 12, 2016

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+29.3%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of NAPROXEN 375 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 375 MG TABLET, manufactured by Cipla USA Inc., is $0.0736 per EA (NDC 69097085407), effective Feb 24, 2021.

How has the price of NAPROXEN 375 MG TABLET changed over time?

Over the history we have for it, the NADAC for NAPROXEN 375 MG TABLET has risen 29.3%. It has been tracked across 229 weekly CMS publications since Oct 12, 2016.

What are the highest and lowest recorded NADAC prices for NAPROXEN 375 MG TABLET?

Since Oct 12, 2016, the NADAC for NAPROXEN 375 MG TABLET has ranged from a low of $0.0548 (Jul 19, 2017) to a high of $0.0801 (Nov 13, 2019), with a median of $0.0653 per EA.

Are there cheaper alternatives to NAPROXEN 375 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as NAPROXEN 375 MG TABLET, but none are currently priced below it.

Who manufactures NAPROXEN 375 MG TABLET?

NAPROXEN 375 MG TABLET (NDC 69097085407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.